What Sets ValueGen.AI Apart
Domain-built, fully traceable, and engineered for the regulated workflows of HEOR and market access teams worldwide.
Domain-Built, Not Generic
Trained and optimized for HEOR and market access — not a general LLM wrapper. Natively understands HEOR methodologies, NICE appraisal logic, and CEA model structures.
Full Traceability
Every output includes source citations and evidence grounding. Outputs are auditable — essential for regulatory submissions and payer negotiations.
Reliability Scoring
Proprietary framework flags outputs by evidence quality, novelty risk, and domain complexity — telling users exactly when to trust vs. verify output.
Wide-Market Coverage
Natively processes HTA reports in French, German, Italian, Spanish, and English — summarizing in English. Covers NICE, G-BA, HAS, ICER, CADTH, AIFA, AEM, and more.
Speed Advantage
Landscape assessments in 48 hours vs. months. Objection handlers in minutes. Frees senior experts for high-value strategic work that requires human judgment.
Enterprise-Grade Security
SSO/Auth0, role-based access control, TLS 1.2 encryption, data encrypted at rest. Client data is never used for model retraining or secondary purposes.
Representative Queries & Use Cases
How HEOR and market access teams put ValueGen.AI to work every day.
HEOR
"Build a cost-effectiveness model for semaglutide vs. liraglutide in type 2 diabetes for a US payer in Excel."
"Estimate the budget impact of lecanemab for early Alzheimer's disease for a Medicare plan and create an online dashboard."
"What evidence gaps exist in HTA submissions for CAR-T therapies in DLBCL?"
Market Access
"Summarize NICE's rationale for rejecting [Drug X] and propose counterarguments for re-submission."
"Create objection handler slides for payers skeptical of tirzepatide's long-term weight maintenance."
"Draft a 1-page payer briefing note justifying Zolgensma's upfront cost vs. lifetime savings."
Standard vs. Premium Tier
Start with the core platform and add advanced modeling, dossier, and country-adaptation modules as needs scale.
| Capability | Standard | Premium Tier |
|---|---|---|
| Natural language query interface | ✓ | ✓ |
| Evidence synthesis & literature intelligence | ✓ | ✓ |
| HTA body insights (NICE, G-BA, ICER, CADTH, HAS, AIFA, AEM) | ✓ | ✓ |
| Conceptual model development & value framework design | ✓ | ✓ |
| Evidence gap identification & prioritization | ✓ | ✓ |
| Deep research agent with full citation traceability | ✓ | ✓ |
| Payer objection insights & value narrative drafts | ✓ | ✓ |
| Query reliability scoring & validation flags | ✓ | ✓ |
| Cost-effectiveness model build (Excel / R) | + | |
| Budget impact model (Excel) | + | |
| Online interactive model & dashboard | + | |
| HTA dossier drafting (NICE, G-BA, CADTH, ICER) | + | |
| Global value dossier generation | + | |
| Country model adaptation packages | + |
Enterprise licensing available · Volume tiers per user at scale · Annual subscription · Custom SOW
See ValueGen.AI in Action
Book a guided walkthrough across HEOR and market access use cases — tailored to your portfolio and priority markets.
Request a Demo